Monday, December 30, 2024
HomeTagsHemispherian

Hemispherian

Hemispherian raises the first tranche of a Series A to fund the development of its novel cancer therapeutics

Hemispherian AS, a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce the closure...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics